Literature DB >> 29594111

Waiting Time following Neoadjuvant Chemoradiotherapy for Rectal Cancer: Does It Really Matter.

Aris Plastiras1, Michail Sideris1, Andy Gaya2, Amyn Haji1, Joseph Nunoo-Mensah1, Asif Haq1, Savvas Papagrigoriadis1.   

Abstract

BACKGROUND: Neoadjuvant chemoradiotherapy (CRT) is considered the standard approach before any surgical intervention for locally advanced rectal tumors and has been proven to significantly improve the local recurrence rates of rectal cancer. However, the optimal timing of surgical resection after neoadjuvant CRT remains debatable. OBJECTIVE AND METHODS: We conducted a retrospective review of 65 consecutive patients with locally advanced rectal cancer who underwent preoperative CRT followed by surgical resection in order to evaluate the optimal time for surgical treatment. We used two alternative groups for analysis: patients who underwent surgery up to 6 weeks after CRT (n = 28) and those who underwent surgery 6 weeks or more after CRT (n = 27). Also, we compared patients who were operated on within 3 months (n = 39) with those who underwent surgical resection after more than 3 months (n = 16). Nonresponders to CRT were excluded from the analysis.
RESULTS: There was no statistically significant association between waiting period post CRT and radiological downstaging for any group (p > 0.05 for any association). Also, there was no association between recurrence of disease, cancer-related deaths, perineural invasion, or positive lymph node ratio and any waiting period up to 3 months (p > 0.05 for all associations).
CONCLUSION: In this small exploratory study there was no evident difference in outcome according to timing of surgery, which suggests that further research in larger cohorts is warranted.

Entities:  

Keywords:  Colorectal cancer; Improvement of prognosis; Neoadjuvant chemoradiotherapy; Therapeutic management

Year:  2017        PMID: 29594111      PMCID: PMC5869555          DOI: 10.1159/000484982

Source DB:  PubMed          Journal:  Gastrointest Tumors        ISSN: 2296-3774


  23 in total

1.  Optimal timing of surgery after chemoradiation for advanced rectal cancer: preliminary results of a multicenter, nonrandomized phase II prospective trial.

Authors:  Julio Garcia-Aguilar; David D Smith; Karin Avila; Emily K Bergsland; Peiguo Chu; Richard M Krieg
Journal:  Ann Surg       Date:  2011-07       Impact factor: 12.969

2.  Locally advanced rectal cancer: histopathological correlation and predictive accuracy of serial MRI after neoadjuvant chemotherapy.

Authors:  D F Johnston; K M Lawrence; B F Sizer; T H A Arulampalam; R W Motson; E Dove; N Lacey
Journal:  Br J Radiol       Date:  2009-04       Impact factor: 3.039

3.  Acute side effects and complications after short-term preoperative radiotherapy combined with total mesorectal excision in primary rectal cancer: report of a multicenter randomized trial.

Authors:  C A M Marijnen; E Kapiteijn; C J H van de Velde; H Martijn; W H Steup; T Wiggers; E Klein Kranenbarg; J W H Leer
Journal:  J Clin Oncol       Date:  2002-02-01       Impact factor: 44.544

4.  Long-term oncologic outcome following preoperative combined modality therapy and total mesorectal excision of locally advanced rectal cancer.

Authors:  Jose G Guillem; David B Chessin; Alfred M Cohen; Jinru Shia; Madhu Mazumdar; Warren Enker; Philip B Paty; Martin R Weiser; David Klimstra; Leonard Saltz; Bruce D Minsky; W Douglas Wong
Journal:  Ann Surg       Date:  2005-05       Impact factor: 12.969

5.  Neoadjuvant therapy for rectal cancer: the impact of longer interval between chemoradiation and surgery.

Authors:  Luiz Felipe de Campos-Lobato; Daniel P Geisler; Andre da Luz Moreira; Luca Stocchi; David Dietz; Matthew F Kalady
Journal:  J Gastrointest Surg       Date:  2010-12-08       Impact factor: 3.452

6.  Preoperative versus postoperative chemoradiotherapy for locally advanced rectal cancer: results of the German CAO/ARO/AIO-94 randomized phase III trial after a median follow-up of 11 years.

Authors:  Rolf Sauer; Torsten Liersch; Susanne Merkel; Rainer Fietkau; Werner Hohenberger; Clemens Hess; Heinz Becker; Hans-Rudolf Raab; Marie-Therese Villanueva; Helmut Witzigmann; Christian Wittekind; Tim Beissbarth; Claus Rödel
Journal:  J Clin Oncol       Date:  2012-04-23       Impact factor: 44.544

7.  Oncologic outcomes after neoadjuvant chemoradiation followed by curative resection with tumor-specific mesorectal excision for fixed locally advanced rectal cancer: Impact of postirradiated pathologic downstaging on local recurrence and survival.

Authors:  Nam Kyu Kim; Seung Hyuk Baik; Jin Sil Seong; Hoguen Kim; Jae Kyung Roh; Kang Young Lee; Seung Kook Sohn; Chang Hwan Cho
Journal:  Ann Surg       Date:  2006-12       Impact factor: 12.969

8.  Evaluation of safety of increased time interval between chemoradiation and resection for rectal cancer.

Authors:  Cam-Ly Tran; Sejal Udani; Alicia Holt; Tracey Arnell; Ravin Kumar; Michael J Stamos
Journal:  Am J Surg       Date:  2006-12       Impact factor: 2.565

9.  Is the delayed surgery after neoadjuvant chemoradiation beneficial for locally advanced rectal cancer?

Authors:  Chia Bin Fang; Caroline Merci Caliari de Neves Gomes; Fernanda Bellotti Formiga; Vanessa Antunes Fonseca; Marineide Prudencio Carvalho; Wilmar Artur Klug
Journal:  Arq Bras Cir Dig       Date:  2013 Jan-Mar

10.  Interval between surgery and neoadjuvant chemoradiation therapy for distal rectal cancer: does delayed surgery have an impact on outcome?

Authors:  Angelita Habr-Gama; Rodrigo Oliva Perez; Igor Proscurshim; Rafael Miyashiro Nunes Dos Santos; Desiderio Kiss; Joaquim Gama-Rodrigues; Ivan Cecconello
Journal:  Int J Radiat Oncol Biol Phys       Date:  2008-01-30       Impact factor: 7.038

View more
  3 in total

1.  Gastrointestinal Malignancies and the COVID-19 Pandemic: Evidence-Based Triage to Surgery.

Authors:  Scott C Fligor; Sophie Wang; Benjamin G Allar; Savas T Tsikis; Ana Sofia Ore; Ashlyn E Whitlock; Rodrigo Calvillo-Ortiz; Kevin R Arndt; Sidhu P Gangadharan; Mark P Callery
Journal:  J Gastrointest Surg       Date:  2020-06-30       Impact factor: 3.452

2.  Optimal interval to surgery after chemoradiotherapy in rectal cancer: A protocol for systematic review and network meta-analysis.

Authors:  Ya Jing Chen; Zhen-Jie Zhao; Bang Wei Wang; Guang Zhuang Jing; Hai-Kun Ma; Xuemei Han; Jiancheng Wang; Zhen-Jie Zhao
Journal:  Medicine (Baltimore)       Date:  2019-11       Impact factor: 1.817

Review 3.  The Interplay among Radiation Therapy, Antibiotics and the Microbiota: Impact on Cancer Treatment Outcomes.

Authors:  Kavery Nivana Theethira Poonacha; Tomás G Villa; Vicente Notario
Journal:  Antibiotics (Basel)       Date:  2022-03-02
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.